Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works

Major lipids, apolipoproteins, and risk of vascular disease

The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works

Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works

Omega-3 Fatty Acids and Cardiovascular Disease

Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771 · see citing works

Loss-of-Function Mutations in <i>APOC3,</i> Triglycerides, and Coronary Disease

The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071 · see citing works

Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia

Phillipson, B. E., Rothrock, D. W., We, C., Harris, W., & Illingworth, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121902 · Cited by 847 · see citing works

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784 · see citing works

Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial

Thies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739 · see citing works

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716 · see citing works

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.07.007 · Cited by 464 · see citing works

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414 · see citing works

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385 · see citing works

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

Bays, H. E., Ballantyne, C. M., Kastelein, J. J., Isaacsohn, J. L., Braeckman, R. A., & Soni, P. N. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.04.015 · Cited by 358 · see citing works

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works

Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells

Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305 · see citing works

Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

Curry, M. D., Alaupovic, P., & Suenram, C. A. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.3.315 · Cited by 286 · see citing works

Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

Wei, M. Y., & Jacobson, T. A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0210-3 · Cited by 284 · see citing works

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070308 · Cited by 282 · see citing works

Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia

Skulas-Ray, A. C., Kris-Etherton, P. M., Harris, W. S., Vanden Heuvel, J. P., Wagner, P. R., & West, S. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003871 · Cited by 280 · see citing works

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.

Blankenhorn, D. H., Alaupovic, P., Wickham, E., Chin, H. P., & Azen, S. P. (1990) · Circulation · doi:10.1161/01.cir.81.2.470 · Cited by 278 · see citing works

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review

Jacobson, T. A., Glickstein, S. B., Rowe, J. D., & Soni, P. N. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.10.018 · Cited by 263 · see citing works

Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells

Kawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F. W., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591743 · Cited by 206 · see citing works

Immunoturbidimetric determination of apolipoproteins A-1 and B in serum

Riepponen, P., Marniemi, J., & Rautaoja, T. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518709168939 · Cited by 198 · see citing works

Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity

Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Redgrave, T. G., & Beilin, L. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.300 · Cited by 185 · see citing works

The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial

Alaupovic, P., Mack, W. J., Knight‐Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184 · see citing works

Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review

Garza, C. A., Montori, V. M., McConnell, J. P., Somers, V. K., Kullo, I. J., & López-Jiménez, F. A. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.2.159 · Cited by 182 · see citing works

Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E

Barthelemy-Clavey, V., Lestavel-Delattre, S., Copin, C., Bard, J., & Fruchart, J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.963 · Cited by 178 · see citing works

Immunoturbidimetric determination of apolipoproteins A-1 and B in serum

Riepponen, P., Marniemi, J., & Rautaoja, T. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518709168939 · Cited by 172 · see citing works

LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients

Lee, S.-J., Campos, H., Moye, L. A., & Sacks, F. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000066131.01313.eb · Cited by 170 · see citing works

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

Sierra‐Johnson, J., Fisher, R. M., Romero‐Corral, A., Somers, V. K., López-Jiménez, F. A., Öhrvik, J., Walldius, G., Hellenius, M.-L., & Hamsten, A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn347 · Cited by 170 · see citing works

Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia

Harris, W. S., Connor, W. E., Inkeles, S. B., & Illingworth, D. R. (1984) · Metabolism · doi:10.1016/0026-0495(84)90230-0 · Cited by 163 · see citing works

Determination of human apolipoprotein e by electroimmunoassay

Curry, M. D., McConathy, W. J., Alaupovic, P., Ledford, J. H., & Popovic, M. (1976) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(76)90078-7 · Cited by 159 · see citing works

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review

Garza, C. A., Montori, V. M., McConnell, J. P., Somers, V. K., Kullo, I. J., & Lopez-Jimenez, F. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60992-0 · Cited by 159 · see citing works

Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines

Davidson, M. H., Corson, M. A., Alberts, M. J., Anderson, J. L., Gorelick, P. B., Jones, P. H., Lerman, A., McConnell, J. P., & WEINTRAUB, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.019 · Cited by 157 · see citing works

A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

Wright, S., O’Prey, F. M., McHenry, M., Leahey, W. J., Devine, A. B., Duffy, E. M., Johnston, D., Finch, M. B., Bell, A. L., & McVeigh, G. E. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077156 · Cited by 151 · see citing works

Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects

Persson, M., Hedblad, B., Nelson, J. J., & Berglund, G. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142679 · Cited by 151 · see citing works

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

Carey, V. J., Bishop, L. M., Laranjo, N., Harshfield, B. J., Kwiat, C., & Sacks, F. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.002 · Cited by 149 · see citing works

Quantitative determination of human apolipoprotein Cc-III by electroimmunoassay

Curry, M. D., McConathy, W. J., Fesmire, J. D., & Alaupovic, P. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90016-8 · Cited by 140 · see citing works

Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A 2

Saougos, V. G., Tambaki, A. P., Kalogirou, M., Kostapanos, M. S., Gazi, I. F., Wolfert, R. L., Elisaf, M., & Tselepis, A. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147280 · Cited by 122 · see citing works

Dose-Response Studies on the Effect of n-3 Polyunsaturated Fatty Acids on Lipids and Haemostasis

Schmidt, E. B., Varming, K., Ernst, E., Madsen, P., & Dyerberg, J. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645675 · Cited by 115 · see citing works

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses

Calabresi, L., Donati, D., Pazzucconi, F., Sirtori, C. R., & Franceschini, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00267-1 · Cited by 104 · see citing works

The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia

Stalenhoef, A. F. H., Graaf, J. D., Wittekoek, M. E., Bredie, S. J. H., Demacker, P. N. M., & Kastelein, J. J. P. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00381-6 · Cited by 101 · see citing works

Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)

Bays, H. E., Braeckman, R. A., Ballantyne, C. M., Kastelein, J. J., Otvos, J. D., Stirtan, W. G., & Soni, P. N. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.07.001 · Cited by 94 · see citing works

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes

Gervaise, N., Garrigue, M. A., Lasfargues, G., & Lecomte, P. (2000) · Diabetologia · doi:10.1007/s001250051366 · Cited by 82 · see citing works

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

Maki, K. C., Bays, H. E., Dicklin, M. R., Johnson, S. L., & Shabbout, M. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.09.001 · Cited by 81 · see citing works

The concept of apolipoprotein-defined lipoprotein families and its clinical significance

Alaupovic, P. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0036-8 · Cited by 81 · see citing works

Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications

Harris, W. S., Dayspring, T. D., & Moran, T. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.11.2717 · Cited by 80 · see citing works

The apolipoprotein story

Sacks, F. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.05.004 · Cited by 75 · see citing works

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Davidson, M. H., Maki, K. C., Bays, H., Carter, R., & Ballantyne, C. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.08.001 · Cited by 71 · see citing works

Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study

Scheffer, P. G., Teerlink, T., Dekker, J. M., Bos, G., Nijpels, G., Diamant, M., Kostense, P. J., Stehouwer, C. D. A., & Heine, R. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.103234 · Cited by 67 · see citing works

All ApoB-Containing Lipoproteins Induce Monocyte Chemotaxis and Adhesion When Minimally Modified

Lee, C., Sigari, F., Segrado, T., Hörkkö, S., Hama, S. Y., Subbaiah, P. V., Miwa, M., Navab, M., Witztum, J. L., & Reaven, P. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.6.1437 · Cited by 63 · see citing works

Lipoprotein‐Associated Phospholipase A2: Review and Recommendation of a Clinical Cut Point for Adults

Lanman, R. B., Wolfert, R. L., Fleming, J. K., Jaffe, A. S., Roberts, W. L., Warnick, G. R., & McConnell, J. P. (2006) · Preventive Cardiology · doi:10.1111/j.1520-037x.2006.05547.x · Cited by 45 · see citing works

Postprandial effect of n–3 polyunsaturated fatty acids on apolipoprotein B–containing lipoproteins and vascular reactivity in type 2 diabetes

Hilpert, K. F., West, S. G., Kris‐Etherton, P. M., Hecker, K. D., Simpson, N., & Alaupovic, P. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.369 · Cited by 44 · see citing works

A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

WRIGHT, S., O’Prey, F. M., McHenry, M. B., Leahey, W. J., Devine, A., Duffy, E., Johnston, D. T., Finch, M., McVeigh, G. E., & Bell, A. L. (2008) · Lara D. Veeken · Cited by 31 · see citing works

Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker

Toth, P. P., McCullough, P. A., Wegner, M. S., & Colley, K. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.18 · Cited by 29 · see citing works

Changes in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements

Inagaki, M., & Harris, W. S. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90045-k · Cited by 26 · see citing works

When is equal not equal?

Sniderman, A. D., Williams, K., McQueen, M., & Furberg, C. D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.01.005 · Cited by 25 · see citing works

Differential Turbidimetric Assay for Subpopulations of Lipoproteins Containing Apolipoprotein A-I

März, W., Trommlitz, M., & Groß, W. (1988) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1988.26.9.573 · Cited by 15 · see citing works

Heterogeneous responsiveness of normolipemic women to n-3 long chain fatty acid supplementation. Changes in serum lipids and apoproteins.

Sánchez-Muniz, F. J., Bastida, S., Quintas, E., Merinero, M. C., & Rodríguez-Gil, S. (1997) · PubMed · Cited by 2 · see citing works

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 488 · see citing works

Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes

Wu, J. H. Y., Micha, R., & Mozaffarian, D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0206-1 · Cited by 167 · see citing works

Predicting the effects of supplemental EPA and DHA on the omega-3 index

Walker, R. E., Jackson, K. H., Tintle, N. L., Shearer, G. C., Bernasconi, A., Masson, S., Latini, R., Heydari, B., Kwong, R. Y., Flock, M., et al. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz161 · Cited by 93 · see citing works

Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism

Detopoulou, P., Demopoulos, C. A., & Antonopoulou, S. (2021) · Nutrients · doi:10.3390/nu13020462 · Cited by 74 · see citing works

Dietary and Pharmacological Fatty Acids and Cardiovascular Health

Wu, H., Xu, L., & Ballantyne, C. M. (2020) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/clinem/dgz174 · Cited by 59 · see citing works

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment

Galimberti, F., Casula, M., & Olmastroni, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106873 · Cited by 63 · see citing works

Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials

Sahebkar, A., Simental‐Mendía, L. E., Mikhailidis, D. P., Pirro, M., Banach, M., Sirtori, C. R., & Reiner, Ž. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1511919 · Cited by 47 · see citing works

Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol

Tian, S., Xing, G., Zhu, J., Zhang, S., Cai, Y., Li, D., Xu, G., Xing, E., Rao, J., & Shi, R. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0617-0 · Cited by 31 · see citing works

Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial

Yang, B., Shi, L. S., Wang, A., Shi, M.-Q., Li, Z.-H., Zhao, F., Guo, X., & Li, D. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05463 · Cited by 29 · see citing works

Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: a randomized controlled trial

Yang, B., Shi, M.-Q., Li, Z.-H., Shi, L., Wang, A.-M., Guo, X.-J., & Li, D. (2019) · Food &amp; Function · doi:10.1039/c8fo01707g · Cited by 28 · see citing works

A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies TM (ALT ® ) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza ®

López-Toledano, M. A., Thorsteinsson, T., Daak, A. A., Maki, K. C., Johns, C., Rabinowicz, A. L., & Sancilio, F. D. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.020 · Cited by 28 · see citing works

Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis

Yi, M., Li, Q., Zhao, Y., Nie, S., Wu, N., & Wang, D. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.07.004 · Cited by 21 · see citing works

Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies

Soto, L. G. D. L. P., Gutierrez-Uribe, J. A., Sharma, A. K., & Ramírez‐Jiménez, A. K. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.035 · Cited by 18 · see citing works

Nutrigenetics, omega-3 and plasma lipids/lipoproteins/apolipoproteins with evidence evaluation using the GRADE approach: a systematic review

Keathley, J., Garneau, V., Marcil, V., Mutch, D. M., Robitaille, J., Rudkowska, I., Sofian, G. M., Desroches, S., & Vohl, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054417 · Cited by 18 · see citing works

Triglyceride Lowering Drugs

Feingold, K. R. (2017) · Europe PMC (PubMed Central) · Cited by 18 · see citing works

Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study

Grytten, E., Laupsa‐Borge, J., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.040 · Cited by 14 · see citing works

Dietary, macronutrient, micronutrient, and nutrigenetic factors impacting cardiovascular risk markers apolipoprotein B and apolipoprotein A1: a narrative review

Nacarelli, G. S., Fasolino, T. K., & Davis, S. C. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad102 · Cited by 12 · see citing works

Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk

Celada, P., Sánchez-Muniz, F. J., Delgado‐Pando, G., Bastida, S., Rodilla, M. E., Jiménez-Colmenero, F., & Olmedilla‐Alonso, B. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0505-5 · Cited by 11 · see citing works

Effects of Alpha-Lipoic Acid Supplementation on Cardiovascular Disease Risk Factors in β-Thalassemia Major Patients: A Clinical Trial Crossover Study

Jamshidi, K., Abdollahzad, H., Nachvak, M., Rezaei, M., Golpayegani, M. R., & Sharifi‐Zahabi, E. (2020) · Journal of Blood Medicine · doi:10.2147/jbm.s252105 · Cited by 11 · see citing works

Various Effects of Omega 3 and Omega 3 Plus Vitamin E Supplementations on Serum Glucose Level and Insulin Resistance in Patients with Coronary Artery Disease.

Saboori, S., Djalali, M., Rad, E. Y., Nematipour, E., Saboor-Yaraghi, A. A., Javanbakht, M. H., Eshraghian, M. R., Ramezani, A., & Koohdani, F. (2016) · PubMed Central · Cited by 10 · see citing works

Effect of Low Dose Docosahexaenoic Acid-Rich Fish Oil on Plasma Lipids and Lipoproteins in Pre-Menopausal Women: A Dose–Response Randomized Placebo-Controlled Trial

Sparkes, C., Gibson, R. A., Sinclair, A. J., Else, P. L., & Meyer, B. J. (2018) · Nutrients · doi:10.3390/nu10101460 · Cited by 10 · see citing works

A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-I Guastalla )

Pisciotta, L., Vitali, C., Favari, E., Fossa, P., Adorni, M. P., Leone, D., Artom, N., Fresa, R., Calabresi, L., Calandra, S., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.09.001 · Cited by 7 · see citing works

Large-scale, comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis

Sun, M., Liu, W., Jiang, H., Wu, X., Zhang, S., & Liu, H. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119832 · Cited by 6 · see citing works

Impact of omega-3 supplementation on lipoprotein-associated phospholipase A2 mass and activity: A systematic review and meta-analysis of randomized controlled trials

Simental-Mendía, L. E., Simental-Mendía, M., Barragán‐Zuñiga, L. J., & Aguillón-Marín, P. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.12.013 · Cited by 4 · see citing works

ApoC-III and ectopic fat accumulation in individuals with type 2 diabetes: an exploratory analysis from the MEDEA randomised controlled study

Costabile, G., Salamone, D., Pepa, G. D., Testa, R., Vitale, M., Brancato, V., Salvatore, M., Soricelli, A., Annuzzi, G., Rivellese, A. A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06464-w · Cited by 2 · see citing works

Targeting Enzymatic Pathways with Marine‐Derived Clinical Agents

Pereira, R. B., Dasari, R., Lefranc, F., Kornienko, A., Robert Kiss, A., & Gomes, N. G. M. (2017) · doi:10.1002/9783527805921.ch10 · Cited by 2 · see citing works

Key Differences Between Hepatic and Intestinal apoC3 Regulation and Expression, and Implications for Cardiovascular Disease Risk

West, G. (2017) · OpenCommons - UConn (University of Connecticut)

Omega-3 supplementation and Lp-PLA2: The importance of the lipoprotein carrier context

Wu, Y. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.01.010

Omega-3 supplementation and Lp-PLA2: Attention to nonindependent comparisons in meta-analysis

Zhao, J., & Yan, J. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.014

Response to the letter regarding "Reanalysis of the impact of omega-3 supplementation on lipoprotein-associated phospholipase A2 mass and activity: A systematic review and meta-analysis of randomized controlled trials"

Simental‐Mendía, L. E., & Simental-Mendía, M. A. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.031

O4-03-05 Dietary omega-3 docosahexaenoic acid DHA regulates CNS insulin signaling and related kinase pathways involved in actin assembly, synaptic plasticity and memory in an Alzheimer (AD) model

Cole, G. M., Zhao, L., Calon, F., Morihara, T., Teter, B., Ambegaokar, S. S., Yang, F., Ashe, K. H., & Frautschy, S. A. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)80268-9

Abstract 19030: Apolipoprotein C-III is Significantly Reduced by Prescription Omega-3 Free Fatty Acids (Epanova) in Patients with Severe Hypertriglyceridemia and Changes Correlate with Increases in LDL-C: A Sub-analysis of the EVOLVE trial

Rader, D. J., Dunbar, R. L., Maki, K. C., Jacobson, T. A., Kling, D. F., & Davidson, M. H. (2012) · Circulation · doi:10.1161/circ.126.suppl_21.a19030 · Cited by 6 · see citing works

Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial

Asztalos, I. B., Gleason, J. A., Sever, S., Gedik, R., Asztalos, B. F., Horvath, K. V., Dansinger, M. L., Lamon‐Fava, S., & Schaefer, E. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.010 · Cited by 74 · see citing works

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158 · see citing works

Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia

Skulas-Ray, A. C., Kris-Etherton, P. M., Harris, W. S., Vanden Heuvel, J. P., Wagner, P. R., & West, S. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003871 · Cited by 280 · see citing works